Sandbox MKK: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
Metronidazole(250-500mg) | Metronidazole(250-500mg) | ||
|BID | |||
QID | |||
QID | |||
TID to QID (500mg) | |||
|10-14 days | |10-14 days | ||
|NO | |NO | ||
|- | |- | ||
|Concomitant | |Concomitant | ||
Line 35: | Line 40: | ||
Nitroimidazole(500mg) | Nitroimidazole(500mg) | ||
|BID | |||
|10 -14 days | |||
|NO | |||
|- | |||
|Sequential | |||
|PPI(standard dose)+Amoxicillin(1gm) | |||
PPI,Clarithromycin(500mg)+Nitroimidazole(500mg) | |||
| | | | ||
| | | | ||
| | | | ||
|} | |} |
Revision as of 15:55, 26 October 2017
TREATMENT
Regimen | Drug dose | Dosing frequency | Duration(days) | FDA approval |
---|---|---|---|---|
Clarithromycin triple | PPI(standard or double dose
Clarithromycin(500mg) Amoxicillin(1gm)or Metronidazole(500mg TID) |
BID | 14 days | YES |
Bismuth Quadruple | PPI(standard dose)
Bismuth subcitrate (120-300mg)or Subsalicylate (300mg) Tetracyclin(500mg) Metronidazole(250-500mg) |
BID
QID QID TID to QID (500mg) |
10-14 days | NO |
Concomitant | PPI (standard dose)
Clarithromycin (500mg) Amoxicillin(1gm) Nitroimidazole(500mg) |
BID | 10 -14 days | NO |
Sequential | PPI(standard dose)+Amoxicillin(1gm)
PPI,Clarithromycin(500mg)+Nitroimidazole(500mg) |